Jiabin Cai

6.1k citations
89 papers · 3.3k indexed · 2 hit papers · h-index 27
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers)Hepatocellular Carcinoma Treatment and Prognosis (11 papers)RNA modifications and cancer (10 papers)

In The Last Decade

Jiabin Cai

86 papers receiving 3.2k citations

Hit Papers

Cancer cell-derived exosomal circUHRF1 induces natural ki...202020262022202420202022100200300400

Peers

Jiabin Cai
Comparison fields: 5 of 118
  • Molecular Biology 2.3k
  • Cancer Research 1.4k
  • Oncology 547
  • Immunology 380
  • Pulmonary and Respiratory Medicine 316
Replace Jiansong Ji with:
Jiansong Ji China
Masayuki Fujii Japan
Hongbo Zhu China
Ruozhen Hu United States
Min Xu China
Fei Ji China
Runzhou Ni China
Mihai Gagea United States
Takuya Fukazawa Japan
Jiabin Cai relative to Jiansong Ji China Jiansong Ji's profile →
Citations per field
00.5×2.6×
Jiansong Ji · 1×
Citations per year

Countries citing papers authored by Jiabin Cai

Since Specialization
Citations

This map shows the geographic impact of Jiabin Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiabin Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiabin Cai more than expected).

Fields of papers citing papers by Jiabin Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiabin Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiabin Cai. The network helps show where Jiabin Cai may publish in the future.

Co-authorship network of co-authors of Jiabin Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Jiabin Cai. A scholar is included among the top collaborators of Jiabin Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiabin Cai. Jiabin Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 5
5 1
6 54
7 7
8 14
9 0
10 2
11 3
12 22
13 7
14 1
15 34
16 8
17 11
18 45
19 24
20 33

About Jiabin Cai

Jiabin Cai is a scholar working on Hepatology, Cancer Research and Oncology, having authored 89 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and RNA modifications and cancer (10 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (2.3k citations) and Hepatology (246 citations). Jiabin Cai has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Ai‐Wu Ke, Jia Fan, Jia‐Cheng Lu, Pengfei Zhang, Guo‐Ming Shi, Xiaoyong Huang, Chao Gao, Xiaojun Guo, Yi-Min Zheng and Jian Zhou. Their work appears in journals such as Journal of the American Chemical Society, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026